-0.035 (-7.29%)

Range 0.445 - 0.470   (5.62%)
Open 0.470
Previous Close 0.480
Buy Price 0.445
Buy Volume 9
Sell Price 0.485
Sell Volume 4
Volume 2
Value 915
Measurement Type Value
EPS (SGD) 0.022
Trailing EPS (SGD) 0.015
NAV (SGD) 0.466
Cash In Hand (SGD) 0.086
Dividend 0.012
Dividend Yield (%) 2.693
PE 20.403
Trailing PE 30.485
Price / NAV 0.956
Price / Cash In Hand 5.174
Issued & Paid-up Shares 253,680,000
Treasury Shares 13,845,000
Market Cap (M) 112.888
Par Value (SGD) n.a.
Beta - 75 Days 1.113
R-Squared - 75 Days(%) 5.63
Beta - 500 Days 0.694
R-Squared - 500 Days(%) 2.33
ISIN Code SG2E64980112
Under CPF Investment Scheme (CPFIS) Yes
Index Components FTSE ST Fledgling
Delayed prices. Updated at 20 Sep 2019 17:16.
Data powered by
View All Events

About Cordlife

Cordlife Group Limited is an investment holding company engaged in the provision of cord blood banking services, which involves the processing and storage of stem cells. The Company operates as a consumer healthcare company. Its segments include Banking, Diagnostic and Others. The banking segment comprises cord blood and cord lining services. The diagnostics segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The Company also releases cord blood units for transplants, and for the treatment of cerebral palsy, as well as for other therapeutic uses. It has processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia, Malaysia and the Philippines.

Loading Chart...

Target Price
Add Stop Loss
Time Frames